Breath test to detect cancer: Study
April 22, 2016
For this study, nanoparticles carrying the anti-cancer drug doxorubicin were introduced to and endocytosed by breast cancer cells. When the cancer cells containing the nanoparticles were then exposed to an oscillating magnetic field, cell death occurred. "The novel magnetic-core silica nanoparticles are effective in activating nanovalves which release anti-cancer drugs when they are exposed to an oscillating magnetic field," Zink said. The magnetic-field oscillation causes the zinc-dop...
BCF publishes two new patient publications
April 21, 2016
BCF will also participate in the Anderson Network Cancer Survivorship Conference at MD Anderson Cancer Center in Houston, TX September 24-25, 2010 and the Metastatic Breast Cancer Conference at Indiana University in Indianapolis, October 19, 2010.BCF is organizing a conference for Physicians and other Health Professionals on October 9, 2010 at the University of Pittsburgh. Clinical Perspectives on the Treatment of Bone Metastasis is designed for oncologists, urologists, or other medical professi...
Researchers identify gene associated with susceptibility to chronic pain caused by nerve injury
April 20, 2016
To further test the potential role for Cacgn2 in chronic pain, the authors utilized a mouse strain harboring a mutant version of the gene that had previously been used in epilepsy research. In testing the mice for behavioral and electrophysiological characteristics of chronic pain, they found that, the observations were consistent with a functional role for Cacgn2 in pain, even though it might be modest.However, the question still remained as to whether the human version of the gene also is impo...
Incyte second-quarter total revenues increase to $49.8 million
April 19, 2016
Net income for the quarter ended June 30, 2010 was $3.0 million, or $0.03 and $0.02 per share on a basic and diluted basis, respectively, as compared to a net loss of $40.0 million, or $0.41 per basic and diluted share, for the same period in 2009. The net loss for the six months ended June 30, 2010 was $32.7 million, or $0.27 per basic and diluted share, as compared to $80.1 million, or $0.82 per basic and diluted share, for the same period in 2009. Included in the net loss for the six months e...
NYU researchers identify novel therapy for rheumatoid arthritis
April 18, 2016
The Yin and Yang of T cells in Rheumatoid Arthritis In rheumatoid arthritis, either an abnormal surge by infection-fighting T cells or a dip in the activity of inflammatory-fighting T cells??”or perhaps both??”could cause the immune system to attack our own joints instead. "Therefore, if you have an abnormal and suppressed regulatory T cell function, you have enhanced potential for autoimmunity," says Dr. Abramson. The researchers bolstered previous evidence for such a link by examinin...